PYC 7.69% 14.0¢ pyc therapeutics limited

The news for battled Voyager shareholders of a licence deal...

  1. 5,184 Posts.
    lightbulb Created with Sketch. 1681
    The news for battled Voyager shareholders of a licence deal uptake by Pfizer illustrates the heating market for low tox solutions in penetrating the brain blood barrier.

    Admittedly a AAV solution, its approach is not so different to ours as in capsulating the adeno virus in capsids to get it passed the barrier.

    Our tox numbers will be exceeding theirs, in my opinion, setting us up for similar staggered
    payment plans.


    The sector is heating up and we are right in the middle of it
    Interesting to note how low its share price was prior to the uptake, bearing clear similarities to our situation.
    I would place us at multiples of their value though, still a valuable comparison in terms of
    price levels prior to the deal.

    Voyager Therapeutics Stock Soars on Pfizer License Deal - MarketWatch


    all IMO
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
0.010(7.69%)
Mkt cap ! $653.2M
Open High Low Value Volume
14.0¢ 14.5¢ 13.0¢ $1.446M 10.38M

Buyers (Bids)

No. Vol. Price($)
3 252759 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.0¢ 113762 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.